Alpine Immune Sciences competitors

Alpine Immune Sciences Competitors include Burzynski Research Institute, PDL BioPharma, GTx and Rexahn Pharmaceuticals.
Add company...
Alpine Immune Sciences
Alpine Immune Sciences
Modern therapies targeting the immune synapse.
Burzynski Research Institute
Burzynski Research Institute
Burzynski Research Institute is primarily engaged as a research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer.
PDL BioPharma
PDL BioPharma
PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities.
GTx
GTx
GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals
Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.
Founding Date
Founding Date
2015
Founding Date
1984
Founding Date
1986
Founding Date
1997
Founding Date
2001
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Houston, US HQ
Stafford, US
Locations
Incline Village, US HQ
Locations
Memphis, US HQ
Locations
Rockville, US HQ
Employees
Employees
N/A
Employees
2
Employees
11
Employees
2219% decrease
Employees
17
Valuation ($)
Valuation ($)
N/A
Valuation ($)
4 m
Valuation ($)
486.1 m
Valuation ($)
22.7 m
Valuation ($)
27.5 m

Financial

Revenue (est.)
Revenue (est.)
$1.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$320.1m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($7.8m) (FY, 2017)
Net income
($1.6m) (FY, 2018)
Net income
N/A
Net income
($30.4m) (FY, 2017)
Net income
($25.3m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 49.3m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 64.7m
Total funding raised
$ 5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Burzynski Research Institute
HQ
Houston, US
Employees
2

Burzynski Research Institute is primarily engaged as a research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer.

View company
PDL BioPharma
HQ
Incline Village, US
Employees
11

PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities.

View company
GTx
HQ
Memphis, US
Employees
22↓ 19% decrease

GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.

View company
Rexahn Pharmaceuticals
HQ
Rockville, US
Employees
17

Rexahn Pharmaceuticals develops treatments for cancer, central nervous system disorders, and other unmet medical needs in the United States.

View company